Note 8 - Inventory |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Notes to Financial Statements | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory Disclosure [Text Block] |
8. Inventory
Inventory, net of reserves, at March 31, 2026 and March 31, 2025 consisted of the following (in thousands):
The Company recorded inventory write-downs of $3.5 million, $1.5 million, and $2.0 million for the fiscal years ended March 31, 2026, 2025, and 2024 respectively. These write-downs were based on the Company's evaluation on its inventory on hand for excess quantities and obsolescence.
Deferred program costs as of March 31, 2026 and March 31, 2025 primarily represent costs incurred on programs where the Company needs to complete performance obligations before the related revenue and costs will be recognized.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||